Skip to main content
Clinical Trials/NCT03382470
NCT03382470
Completed
Not Applicable

Partnership to Enhance Antimicrobial Use in Resource-Limited Settings (PEARL): An Assessment of Need and Feasibility of Antimicrobial Stewardship Programs

Duke University1 site in 1 country3,115 target enrollmentMarch 12, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Resistance Bacterial
Sponsor
Duke University
Enrollment
3115
Locations
1
Primary Endpoint
Appropriate antimicrobial use, for example for urinary syndromes
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Antimicrobial resistance is one of the greatest threats to human health, and is driven by inappropriate antimicrobial use. Antimicrobial stewardship programs (ASPs) improve the use of antimicrobials in hospitals. The purpose of this study is to identify the need for and barriers to implementation of ASPs in three hospitals in Sri Lanka, Kenya, and Tanzania.

Detailed Description

Antimicrobial resistance is one of the greatest threats to human health, and is driven by the inappropriate antimicrobial use. Antimicrobial stewardship programs (ASPs) improve the use of antimicrobials. The purpose of this study is to identify the need for and barriers to implementation of ASPs in three hospitals in Sri Lanka, Kenya, and Tanzania. The impact of creating a basic ASP will be assessed at each hospital.

Registry
clinicaltrials.gov
Start Date
March 12, 2018
End Date
March 8, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All patients admitted to the medical wards -

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Appropriate antimicrobial use, for example for urinary syndromes

Time Frame: 6 months

A composite outcome will be created for 'inappropriate' antibiotic use. This outcome will consist of 1) Unnecessary treatment for asymptomatic bacteriuria, 2) Inappropriate duration of therapy for urinary tract infection (UTI)/ cystitis/ pyelonephritis (binary outcome- yes/no), and 3) Unnecessary double coverage for UTI/ cystitis/ pyelonephritis (binary outcome- yes/no)

Study Sites (1)

Loading locations...

Similar Trials